DOH execs may face raps over remdesivir purchases —solon

Department of Health officials may face criminal charges if they insist on buying further supplies of remdesivir despite the World Health Organization recommendation against the drug’s use on COVID-19 patients, Rep. Michael Defensor said Sunday.

"We consider all new purchases of remdesivir as reckless and foolish spending in light of the WHO recommendation, and considering that government is scrounging for money to buy more COVID-19 vaccines and to pay for the P2,000 cash aid for every Filipino contemplated under the Bayanihan 3 bill," Defensor said in a statement.

“All further purchases of remdesivir -- after the WHO came out with its adverse recommendation -- may be deemed as transactions highly detrimental to the government under the Anti-Graft and Corrupt Practices Act,” he added.

Citing the law, the lawmaker said DOH officials may be held liable for performing a transaction that is "grossly disadvantageous" to the government.

According to him, the offense is punishable with up to 10 years in prison, and perpetual disqualification from public office.

Further, Defensor said, “We would urge the Department of Budget and Management to repurpose the money meant for remdesivir, preferably to acquire more COVID-19 vaccines.”

Also citing WHO data, Defensor said, "remdesivir had no important effect” in reducing the need for mechanical ventilation, shortening the time to clinical improvement, lessening the risk of mortality and on other COVID-19 patient outcomes.

“The problem with remdesivir is its outrageous price, and yet, based on the findings of the WHO, the drug offers no significant relief to patients,” Defensor added. —LBG, GMA News